Skip to main content
. 2019 Oct 31;2019(10):CD003698. doi: 10.1002/14651858.CD003698.pub3

Sinclair 1998.

Methods Country: United Kingdom
Design: Cluster‐randomised controlled trial of community pharmacies and pharmacy customers
Study objective: To evaluate a training workshop for community pharmacy personnel to improve their counselling in smoking cessation based on the stage‐of‐change model
Method of analysis: Multiple logistic regression
Clustering adjustments made: "The estimates of intra‐cluster correlation (p) for the outcomes at each time point were calculated". The effects of clustering were negligible
Participants Eligible for study: Pharmacies n = 76 (775 patients)
Randomised: Pharmacies n = 62 (Patients: Intervention n = 224; Control n = 268)
Completed: Pharmacies: Intervention n = 31; Control n = 29 (Patients: Intervention n = 159; Control n = 188)
Age: Intervention 41.7; Control 41.5
Gender: Men n = 185; Women n = 302
Inclusion criteria: Pharmacy customers seeking advice on stopping smoking or buying an OTC anti‐smoking product in preparation for a new attempt to stop smoking; Recruitment period 12 months; No limit to number of recruits per pharmacy
Interventions Setting: rural community pharmacies, Grampian, Scotland
Intervention description: 2‐hour training workshop for pharmacists and pharmacy assistants: based on stages‐of‐change model and communication skills for negotiating change and providing ongoing support; no focus on smoking cessation products. Trained pharmacy staff offered participants the Pharmacy Support Programme which involved participant registration, counselling and ongoing record keeping at each subsequent purchase of OTC medications
Control description: Usual care, mandated by UK law as a minimum of the display of health education material
Duration of intervention: "Brief", exact time not specified
Outcomes Prespecified outcomes: Self‐reported point prevalence of smoking at 1 month and continuous abstinence at 4 and 9 months; Age, gender, postcode (proxy for socioeconomic status), nicotine dependence (Fagerström test) recorded at 1 month post‐intervention; Consumer response to structured questionnaire assessing perception of the support package at 4 months
Follow‐up period: 1, 4 and 9 months
Self‐reported point prevalence at 1 month, continuous abstinence at 4 and 9 months
Notes No additional pharmacy reimbursement. Evaluated effects of clustering by calculating ICCs for each outcome; concluded no evidence of significant cluster effect
Funding: The Scottish Office, Department of Health
Declarations of interest: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No details of randomisation methods
Allocation concealment (selection bias) Unclear risk No information on allocation concealment methods
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Quote: “Nine‐month smoking data were provided by a total of 73.2% (347) of the recruited customers: 73.3% (159) intervention and 73.2% (188) controls”
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Abstinence not biochemically validated
Quote: “Intervention personnel offered their customers the Pharmacy Support Programme, which involved client registration, counselling, and record keeping. The control group asked customers to register and then continued to provide standard professional support.”
Comment: Based on this description it is not clear if different amounts of face‐to‐face contact were provided
Selective reporting (reporting bias) Unclear risk No published protocol. All outcomes planned in the Methods section report on in the Results

CO: carbon monoxide; ICC: intra‐class correlation coefficient; ITT: intention‐to‐treat; MI: motivational interviewing; OTC: over the counter;